With the appointment of Dr. Sharon Rozenblat to th
Post# of 15624
(Total Views: 358)
Posted On: 04/15/2017 11:55:34 PM
With the appointment of Dr. Sharon Rozenblat to the OWCP advisory team, I'm sure they are working on the treatment of melanoma as well. She obtained her doctorate researching melanoma!!!
Dr. Rozenblat earned her doctorate in Biochemistry and Cell Biology from Bar Ilan University in Israel, where her research focused on botanical components as therapeutic agents for melanoma. She has authored and contributed to numerous papers and is a frequent speaker at dermatological events, including the three most recent American Academy of Dermatology (AAD) annual meetings.
http://www.prnewswire.com/news-releases/owc-p...02483.html
Dr. Rozenblat earned her doctorate in Biochemistry and Cell Biology from Bar Ilan University in Israel, where her research focused on botanical components as therapeutic agents for melanoma. She has authored and contributed to numerous papers and is a frequent speaker at dermatological events, including the three most recent American Academy of Dermatology (AAD) annual meetings.
http://www.prnewswire.com/news-releases/owc-p...02483.html
(2)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼